Combipres
$ 50,00 – $ 202,00Price range: $ 50,00 through $ 202,00
Combivir
$ 86,00 – $ 513,00Price range: $ 86,00 through $ 513,00
Combivent
$ 128,00 – $ 384,00Price range: $ 128,00 through $ 384,00
Combivent is a highly effective combination medication designed to manage the symptoms of chronic obstructive pulmonary disease (COPD). It contains two active ingredients, ipratropium bromide and albuterol, which work together to relax the muscles in the airways. This dual-action formula helps to significantly increase airflow to the lungs, making breathing easier for patients with chronic bronchitis or emphysema. The inhaler is specifically indicated for individuals who require a second bronchodilator to control their ongoing respiratory symptoms. Consistent use of this medication helps prevent wheezing, shortness of breath, and coughing associated with long-term lung conditions.
Active substance: albuterol, ipratropium
SKU:
Combivent
Category: Other
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Combivent – Information for Patients and Caregivers
Combivent belongs to a class of combination respiratory medications containing an anticholinergic agent and a beta-2 adrenergic agonist. It is indicated for the management of bronchospasm in patients diagnosed with chronic obstructive pulmonary disease (COPD) who require more than one bronchodilator.
In the United States, this medication is available strictly by prescription in accordance with federal regulations. Treatment plans and dosage schedules must be determined by a licensed healthcare professional based on individual clinical evaluation.
Basic Information
| Parameter | Details |
|---|---|
| Drug Name | Combivent |
| Active Ingredients (INN) | Ipratropium bromide and albuterol sulfate |
| Therapeutic Class | Anticholinergic and beta-2 adrenergic agonist combination |
| Dosage Form | Inhalation spray (Respimat delivery system) |
| Route of Administration | Oral inhalation |
| Prescription Status | Prescription only (Rx) |
| Primary Purpose | Management of bronchospasm in COPD patients requiring dual-bronchodilator therapy |
Main Uses
Combivent is explicitly approved by the U.S. Food and Drug Administration (FDA) for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) in patients who continue to experience symptomatic airway obstruction despite regular use of a single aerosol bronchodilator. COPD includes conditions such as chronic bronchitis and emphysema.
The combination therapy is designed for maintenance treatment when single-agent bronchodilator therapy proves insufficient to maintain adequate pulmonary function. It is not approved for the initial treatment of acute bronchospastic episodes requiring immediate emergency rescue intervention, nor is it routinely indicated for asthma management unless specified by a physician. Any off-label application must be directed and monitored by a qualified healthcare provider.
How the Drug Works
The clinical action of Combivent relies on the complementary pharmacologic effects of its two active constituents: ipratropium bromide and albuterol sulfate. These agents target different receptor sites in the lower respiratory tract to achieve effective relaxation of bronchial smooth muscle.
Ipratropium bromide acts as an anticholinergic (antimuscarinic) agent. It blocks muscarinic M3 receptors located on airway smooth muscle, inhibiting acetylcholine-mediated bronchoconstriction and reducing vagal tone. Albuterol sulfate is a selective beta-2 adrenergic agonist. It stimulates intracellular adenyl cyclase, triggering an increase in cyclic adenosine monophosphate (cAMP). Elevated cAMP levels reduce intracellular calcium concentrations, resulting in smooth muscle relaxation throughout the bronchial tree. Combining these mechanisms produces greater bronchodilation than either drug administered alone at recommended doses.
What Happens in the Body
Following oral inhalation, both ipratropium bromide and albuterol sulfate act locally within the lungs. A portion of each dose is swallowed and absorbed via the gastrointestinal tract, while the deposited pulmonary fraction enters systemic circulation through bronchial tissue.
Ipratropium bromide exhibits minimal systemic absorption. Plasma concentrations following inhalation remain extremely low. It is partially metabolized into inactive ester hydrolysis products and eliminated primarily through renal and fecal pathways. Albuterol sulfate is readily absorbed from the respiratory tract. It undergoes hepatic metabolism into an inactive conjugate (albuterol-4′-O-sulfate) and is rapidly excreted in the urine. The mean plasma elimination half-life of inhaled albuterol ranges from 3 to 6 hours in healthy adults.
Dosing Schedule
Combivent is administered via oral inhalation using the dedicated Respimat inhaler device. Dosing must follow specific clinical guidelines to maintain steady therapeutic efficacy while minimizing potential adverse effects.
The standard prescribed dose for adult patients with COPD is one inhalation four times daily. If necessary, patients may take additional inhalations under medical advice; however, total daily administration must not exceed six inhalations in any 24-hour period. Proper priming of the device is mandatory prior to first use or when the inhaler has not been actuated for more than 21 days. Patients should inhale slowly and deeply through the mouthpiece while actuating the device, followed by holding their breath for 10 seconds or as long as comfortable.
If You Skip a Dose
If a dose of Combivent is missed, it should be taken as soon as the patient remembers. However, if it is almost time for the next scheduled inhalation, the missed dose should be skipped entirely, and the normal dosing schedule should be resumed.
Patients must never administer a double dose or take extra inhalations to compensate for a missed dose. Overuse of beta-adrenergic agonists increases the likelihood of systemic adverse reactions, such as tachycardia, cardiac arrhythmias, and excessive blood pressure fluctuations.
Compatibility With Other Medicines
Combivent has documented interactions with several classes of pharmaceutical agents. A complete medication review is necessary before starting therapy to prevent adverse drug reactions.
- Beta-adrenergic blockers: Non-selective beta-blockers (such as propranolol) inhibit the bronchodilating effect of albuterol and may induce severe bronchospasm in COPD patients.
- Diuretics: Non-potassium-sparing diuretics combined with beta-agonists can exacerbate hypokalemia and cause electrocardiographic changes.
- Monoamine oxidase inhibitors (MAOIs) and Tricyclic antidepressants (TCAs): These agents may potentiate the cardiovascular actions of albuterol, increasing the risk of hypertension and severe arrhythmias.
- Other anticholinergic agents: Co-administration with anticholinergic medications may lead to additive systemic anticholinergic effects, such as urinary retention or elevated intraocular pressure.
Adverse Reactions
Clinical trials indicate that Combivent is generally tolerated, but side effects can occur due to local pulmonary exposure and systemic absorption of its component drugs.
Commonly reported mild-to-moderate side effects include upper respiratory tract infections, cough, bronchitis, headache, dry mouth, and mild gastrointestinal distress such as nausea. Because albuterol is a sympathomimetic amine, patients may experience nervous system stimulation resulting in fine skeletal muscle tremors, nervousness, dizziness, and peripheral vasodilation.
Cardiovascular side effects may manifest as transient increases in heart rate, palpitations, or mild blood pressure elevation. Most mild side effects diminish as therapy continues, but persistent symptoms require medical review.
Red Flags
Certain clinical signs mandate immediate medical evaluation and emergency care. Patients should be aware of potential serious adverse reactions associated with combination bronchodilator therapy.
| Warning Sign | Possible Clinical Cause | Required Action |
|---|---|---|
| Paradoxical bronchospasm | Acute hypersensitivity or airway hyper-reactivity | Stop using Combivent immediately and seek emergency medical care. |
| Severe chest pain or rapid heart rate | Systemic beta-adrenergic cardiac stimulation | Seek immediate emergency medical evaluation. |
| Eye pain, blurred vision, or visual halos | Accidental ocular exposure or acute narrow-angle glaucoma | Consult an ophthalmologist or urgent care provider immediately. |
| Difficulty urinating or painful urination | Anticholinergic urinary retention | Contact prescribing physician promptly. |
| Severe facial swelling, rash, or throat tightness | Systemic allergic reaction / Anaphylaxis | Obtain immediate emergency medical intervention. |
Important Precautions
Combivent requires careful clinical monitoring in patients with underlying systemic conditions. Sympathomimetic amines like albuterol can cause significant cardiovascular effects, including altered pulse rate, elevated systolic blood pressure, and ECG changes. Caution is required in individuals with ischemic heart disease, cardiac arrhythmias, hypertension, hyperthyroidism, or convulsive disorders.
Due to the anticholinergic component (ipratropium bromide), Combivent must be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder-neck obstruction. If acute COPD worsening occurs–characterized by a reduced duration of relief from standard doses–patients should not increase dosage independently; this signals clinical deterioration requiring medical reassessment.
Special Populations
The safety and effectiveness of Combivent in pediatric patients have not been established. The drug is not indicated for use in children.
Clinical data do not show overall differences in safety or efficacy between elderly patients and younger adults. However, greater sensitivity to anticholinergic or beta-agonist effects in some older individuals cannot be ruled out. In pregnant or nursing women, Combivent should be used only if the expected therapeutic benefit justifies potential risks to the fetus or infant, as controlled clinical studies in pregnant women are limited.
Storage and Expiration
Combivent Respimat must be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C and 30°C). Protect the unit from freezing, high humidity, and direct heat exposure.
Once the Respimat cartridge is inserted and assembled, the inhaler must be discarded within 3 months of first use or when the dose indicator shows that the container is empty, whichever comes first. Keep the device out of the reach and sight of children.
Common Questions
Can Combivent be used as a sudden rescue inhaler during an acute asthma attack?
Combivent is not indicated for the primary treatment of acute asthma attacks or acute bronchospastic crises where immediate high-dose rescue bronchodilation is required. It is designated for maintenance therapy in COPD. Patients experiencing sudden, severe breathing difficulty should follow their prescribed emergency rescue protocol using a fast-acting single-agent bronchodilator as directed by their physician.
Is it safe to consume caffeinated beverages while using Combivent?
Caffeine is a central nervous system and cardiac stimulant with mild xanthine-like properties. Consuming high amounts of caffeine while using Combivent may enhance sympathomimetic side effects, such as increased heart rate, nervous tremors, and palpitations. Patients are advised to moderate caffeine intake and discuss dietary habits with their healthcare provider.
What should I do if Combivent is accidentally sprayed into my eyes?
Accidental spray into the eyes can cause temporary visual disturbances, blurred vision, eye pain, and pupillary dilation. If exposure occurs, flush the eyes thoroughly with clean water immediately. Individuals with a history of narrow-angle glaucoma must exercise extreme caution, as ocular absorption of ipratropium bromide can precipitate an acute glaucoma attack requiring emergency medical care.
How does Combivent differ from using an albuterol-only inhaler?
An albuterol-only inhaler contains a single short-acting beta-2 agonist that relaxes smooth muscles via adrenergic pathways. Combivent combines albuterol with ipratropium bromide, an anticholinergic drug. This dual combination targets two distinct physiological mechanisms simultaneously, resulting in superior bronchodilation compared to albuterol alone in patients with COPD.
Can Combivent affect blood glucose levels in patients with diabetes?
Like other beta-adrenergic agonists, the albuterol component of Combivent can potentially cause transient increases in blood glucose levels due to stimulation of glycogenolysis. Patients with diabetes mellitus should monitor their blood glucose concentrations closely when initiating or adjusting treatment with Combivent.
In accordance with FDA requirements.
This content is informational and does not replace a consultation with your doctor or pharmacist.
Additional information
| Dosage |
100mcg+20mcg |
|---|---|
| Package |
1 inhaler ,2 inhaler ,3 inhaler |
| Ενεργός Ουσία | , |
Related products
Actigall
$ 60,00 – $ 521,00Price range: $ 60,00 through $ 521,00
Active substance: Ursodiol
More Details
This product has multiple variants. The options may be chosen on the product page
Arcalion
$ 25,00 – $ 50,00Price range: $ 25,00 through $ 50,00
Active substance: Sulbutiamine
More Details
This product has multiple variants. The options may be chosen on the product page
Azilect
$ 17,00 – $ 46,00Price range: $ 17,00 through $ 46,00
Active substance: Rasagiline
More Details
This product has multiple variants. The options may be chosen on the product page
Ciprodex Ophthalmic Solution
$ 63,00 – $ 95,00Price range: $ 63,00 through $ 95,00
Active substance: Ciprofloxacin, Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Eurax Lotion
$ 3,00 – $ 15,00Price range: $ 3,00 through $ 15,00
Active substance: Crotamiton
More Details
This product has multiple variants. The options may be chosen on the product page
Imusporin
$ 117,00 – $ 535,00Price range: $ 117,00 through $ 535,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
Levothroid
$ 42,00 – $ 144,00Price range: $ 42,00 through $ 144,00
Active substance: Levothyroxine sodium
More Details
This product has multiple variants. The options may be chosen on the product page
Modvigil
$ 61,00 – $ 759,00Price range: $ 61,00 through $ 759,00
Active substance: Modafinil
More Details
This product has multiple variants. The options may be chosen on the product page
